Research & Development: Page 102
-
PharmaVoice Team/PharmaVoice
Table of Contents
Teri Cox says the public isn’t aware of the industry’s role in patient advocacy. Dr. Paul Bleicher says it’s important to consider what components of a CRO will be used when determining budgets. Contents Richard Pascoe says leadership is understanding what motivates people. July 2005 On the Cover...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Letters Are Drug Safety Concerns Endangering Drug Benefits? The best way to avoid draconian restrictions on consumer and doctor access to the world’s most innovative medicines is to strike an appropriate balance between benefits and risks. — Rob Norton A Congressional overreaction For starters, I...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Communicating cooperatively Letter from the Editor July 2005 In June, an unprecedented number of exhibitors and attendees convened in Washington, D.C., to attend the annual Drug Information Association (DIA) conference. The DIA annual meeting provides a neutral forum for regulators, academics, an...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool July 2005 Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Dr. Marcus Carr Novo Nordisk Names Chief Medical Officer Marcus Carr, M.D., Ph.D., has joined Novo Nordisk as chief medical officer and executive director for clinical research of the hemostasis gro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
July 18-19 The 2nd Annual Strategic Medicare Compliance and Administration Summit Ritz Carlton Hotel, Tysons Corner, Va. For more information, contact Jon Stock, The Center for Business Intelligence, at 800-817-8601, e-mail [email protected], or visit cbinet.com. July 18-19 9th International Out...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents Letter from the Editor Forum on Marketing Modern Marketing in the Making: Marketing executives from pharmaceutical, biotechnology, device, and diagnostic companies, ranging in size from small specialty to midtier to large and global, share common challeng...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Industry Events October 15-16, 2003, Wardman Park Marriott Hotel — Washington, D.C. eSubmissions for Global Compliance This Marcus Evans conference will focus on electronic document management and publishing. Key topics will include an ICH update, changes in eCTD specifications, CDISC data standa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaCounsel
The Effects of the HIPAA Privacy Policy Rule on Clinical Research and Registries On April 14, 2003, the privacy rule took effect and most covered entities must now comply with its provisions. The rule establishes minimum federal standards for safeguarding the privacy of individually identifiable ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
Dendrite Launches Sample Program Dendrite International Inc. has launched its One-Source Sample program, which serves the entire life cycle of sample-product promotion and blends market-leading software applications with best-in-class consulting and professional services. Helping to ensure compli...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Clinical Services: The Evolving Role of the Technology Vendor
The E-Arena etrials Worldwide Inc. With the extensive e-clinical options available to trial sponsors, as well as the continued advancement of technology, there is no question that careful consideration must be given to what tools to employ in clinical-trial research. But choosing a solution d...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Site Qualification and Training: Immediate Time, Cost, and Performance Improvements
ePharmaLearning Inc. ePharmaLearning Inc., Conshohocken, Pa., is an industry leading site qualification, clinical e-learning, and site activation company. For more information, visit epharmalearning.com. The keys to improving a clinical trial’s operational success include selecting the b...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Timely Enrollment and Retention: Keys to a Successful Clinical Trial
Ultimately, trial enrollment will always require extensive human interaction between all interested parties. Tools that can facilitate the magic that occurs when new methods of treatment get to market can change lives. Key to a successful clinical trial is timely enrollm...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Clinical Teams Say Sites Can Do Recruitment, But Can They?
Clinical Teams Say Sites Can Do Recruitment, But Can They? Why a fixed budget for every site sets up a study for failure. Patient Recruitment The best strategy is to customize recruitment campaigns to ensure that recruitment is timely and cost-effective. El...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Five Steps to Successful Electronic Data Management Vendor Selection
While the pharmaceutical industry has been working to adopt e-clinical technology for more than a decade, almost 70% of e-clinical technology implementations fail to meet expectations. Why the lack of success? There are countless reasons, but one of the most important is the complexity surroundin...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Investigator Initiated Trials: The 800-Pound Gorilla
The Clinical-Trial Process Investigator initiated trials (IITs) can be a significant boon to a company with a new drug or device or sometimes even an older product. Why? Because physicians are engaging in something they truly want to do (it’s their idea, after all), at a cost that’s generally ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Improving Clinical-Trial Performance
The Clinical-Trial Process Improving Clinical-Trial Performance Effectively managing the vast number of dispersed resources involved in conducting a clinical trial requires a cohesive approach that assures clinical study and regulatory knowledge to achieve hig...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Clinical Document Development: Planning for Accelerated Timelines
Jean Hosutt, Ph.D., Director, Medical Regulatory Writing Clinical Document Development: Planning for Accelerated Timelines clinical document development Active planning is required to facilitate the partnership between the sponsor and medical-writing contractor resultin...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Clinical Data Strategies for Performance Optimization
Octagon Research Solutions Inc. Data Standards Organizations that hesitate to embrace these standards as opportunities will be at a competitive disadvantage. They will continue to struggle with the tactical “cost” of transforming the ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The Drug Information Association (DIA) will play host to the largest group of exhibitors and attendees in its 41-year history. More than 815 exhibit booths representing more than 550 companies will be in attendance at the Washington Convention Center in Washington, D.C., June 26-June 30, 2005, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Letter from the Editor The Forum Clinical Services: Outsourcing: A Vital Clinical Strategy — A large, unmet need exists for improved research and development (R&D) productivity within pharmaceutical and biotechnology companies. Outsourcing discovery research, clinical trials, and f...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Phase IV Juggernaut: Best Practices for Success
Dimensional HealthCare Inc. Late-stage success depends on an in-depth understanding of the Phase IV scientific drivers, the commercial objectives, and the integration of clinical and marketing knowledge. Adam Serody VP, Clinical Solutions The Phase IV Juggernaut: ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
CME Programs Accredited by Universities and Societies Receive Preference Continuing medical education (CME) programs created by medical communications agencies achieve a higher level of acceptance among physicians when they are accredited through partnerships with respected university medical sch...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Translational Research: Making the Transition from R to D
Translational Research: Making the Transition from R to D There is a growing interest in translational research, which aims to bridge the gap between advances in basic research and the development of safe and effective therapies. June 2005 PharmaVOICE Despite increased investment in research and ...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
Clinical-Trial Transparency: The Pros and Cons Representing Biotech with David King DTC: The Next Evolution PharmaVOICE www.pharmavoice.com June 2005 Volume 5, Number 6 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover The time for transparency The government, medical journal editors, and general public are clamoring for the pharmaceutical industry to provide complete information about ongoing and completed clinical trials. There has been a flurry of activity, announcements, and mandates in this ar...
By PharmaVoice Team • Jan. 2, 2008
Previous
